(firstQuint)A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection.

 Patients are randomized to one of four treatment arms.

 ddC is administered at 1 of 2 doses every 8 hours.

 AZT is administered at 1 of 2 doses (every 4 hours while awake or every 8 hours).

.

 A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection@highlight

To investigate the appropriate zalcitabine ( dideoxycytidine; ddC ) dose and zidovudine ( AZT ) schedule for use in combination therapy in patients with HIV infection.

